Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with those among the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and medical suppliers to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.
Pharma Sources Insight April 2023 focuses on the following topics and more:
The UK Medicines and Healthcare products Regulatory Agency granted conditional marketing approval for Vertex & CRISPR Therapeutics’ Casgevy to treat Sickle Cell Disease and transfusion-dependent beta thalassemia on November 16, 2023.
The first step in creating a new medication is to gain as much knowledge as you can about the illness or condition. Basic research offers hints about prospective treatment approaches for illnesses, including addressing their symptoms or underlying causes.